Dayra
dayra.co
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$3M
1 round on record
Latest round
$3M
Venture round · Mar 2021 · 5 yr ago
Backers
1
Y Combinator
The money's age
Long since its last round
66 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2021 | $3M | — | crowdfundinsider.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Y Combinator Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Get Top deals, latest Coupons & Discount Codes for [1500+ Sites]. Backed By Mr. Ratan Tata CashKaro is a True place to Avail Extra Cashback…
KreditBee is an instant personal loan platform that lets users avail credits up to 2lakhs within 15 minutes through its online tech-based…
Medium Help About Contact Jobs Download Medium Help About Contact Jobs Download Medium Help About Contact Jobs ABOUT US Mask Network aims…
Pluang is a financial technology application that opens public access opportunities to financial products easily and affordably. It aims to…
Aviwell aims to nourish the planet with sustainable microbiota-based solutions. At a fraction of the cost..
Slikk is a fashion brand that aims to deliver value within seconds and drip within minutes.
News
Biogen Inks Research Deal With Dayra to Boost Immunology Pipeline
BIIB's research deal with Dayra targets oral macrocyclic peptides to advance its immunology pipeline and expand next-generation therapies.
Read more
Report
Dayra Therapeutics secures Biogen partnership and $70M before officially opening its doors
Read more
Report
Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions
CAMBRIDGE, Mass. and TORONTO, Nov. 24, 2025-- Biogen Inc. and Dayra Therapeutics today announced a research collaboration to discover and develop oral macrocyclic peptides for priority targets in immunological conditions. "With this collaboration, we are
Read more
Report
Financials
Total raised
$3M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2021 | $3M | Details |